Scott Thielman

CTO at Product Creation Studio

"I've been chasing the wrong problem for two years. Like many engineers captivated by AI's potential, I initially saw workflow automation as the solution—imagine an AI system that could draft our proposals and accelerate our entire business development process at Product Creation Studio. The vision was seductive: decades of project patterns synthesized into intelligent automation.


The reality was humbling. When I presented my AI-generated proposals to the team, their resistance was immediate and instructive. 'This suggests deliverables we've never offered,' one engineer observed. The AI was over-generating, producing plenty of contentbut missing the nuanced context that separates viable projects from risky ones.


Granted, there were opportunities for further tuning, but my team was more focused on getting to the relevant truths about the opportunity than they were at fixing the overly verbose agent. What they really wanted wasn't an automated workflow, but access to the right context to make their own decisions rapidly. Teams want to come up to speed themselves before committing their reputation to a delivery promise.


This insight led to Project Nancy—not a workflow automator, but a context orchestrator. Still in development, Nancy applies model-based intelligence to how the project data is stored and retrieved, applying multiple database technologies in unison to increase the relevant insights that are returned. She's not replacing human judgment—she's amplifying it with the right context at the right moment. And that shift from automation to amplification has fundamentally changed how I think about AI's role in product development."


Scott Thielman

Scott Thielman, PhD, is Chief Technology Officer and Co-Founder of Product Creation Studio, where for over 25 years he has led product development for medical device innovators including Olympus, Cardinal Health, Advanced Bionics, and LumiThera. His work spans critical medical technologies—from deep brain stimulation systems and insulin delivery devices to ophthalmic therapy devices and automated molecular therapy systems.

At Product Creation Studio, Scott has guided teams through complex development challenges, including human factors research, design for manufacturing, and regulatory preparation for Class II and Class III medical devices. Notable projects include LumiThera's Valeda photobiomodulation device (successfully acquired by Alcon in 2025), neurosurgical repair devices, and needle-free vaccine delivery systems. 

Scott's technical foundation in control systems and optimization—developed during his PhD work at the University of Washington on electromagnetic suspension and composite flywheel design—provided early exposure to the mathematical principles underlying modern AI. Since 2023, he has actively integrated AI tools into Product Creation Studio's workflows, developing custom applications for CRM reporting and proposal automation. As an Affiliate Assistant Professor at UW Bothell, he created and taught a course on AI in Product Engineering, helping students apply these tools to real-world engineering challenges.

Recommended

2025 Enzzo, Inc. All Rights Reserved.

2025 Enzzo, Inc. All Rights Reserved.

2025 Enzzo, Inc. All Rights Reserved.